photo-1432691301971-c8b920198bd7.jpg

About

 

Melbourne Stem Cell Centre is committed to the ethical development and clinical application of stem cell therapies in the area of regenerative medicine. MSCC follows the National Health and Medical Research Councils guidelines for cell based therapies. Working closely with partners Magellan Stem Cells, MSCC is an industry leader in the area of stem cell research for the treatment of arthritis and other joint disorders. MSCC is a founding member of the Australian Consortium of Autologous Cell Users and abides by its industry code of ethics.

 
MSCC Team Image For Web.jpg

Meet our Sports Medicine Doctors...

 

Dr Julien Freitag

Head of Clinical Research

Associate Professor/Sports Medicine Physician

Assoc. Prof. Julien Freitag's practice is focused on the active management of musculoskeletal conditions including osteoarthritis. He is an authority in the area of clinical regenerative musuloskeletal medicine and has published numerous articles, including those in peer reviewed international journals. He is the Principal Clinical Investigator in a number of world leading research projects assessing the benefits of stem cell therapy in arthritis.  His work in the field of clinical translational development was recognized by Charles Sturt University with his appointment as an Adjunct Associate Professor.  He is a member of the International Cartilage Repair Society and the Australasian Society of Stem Cell Research.

 
MSCC our Lab.jpg

Our Associates 

 

Magellan Stem Cells

Magellan Stem Cells operates a specialised stem cell laboratory in Melbourne that provides stem cell services to doctors throughout Australia. Magellan Stem Cells is seeking to work with doctors who are treating patients who have conditions that can benefit from the provision of stem cell therapies.

www.magellanstemcells.com

 
Melbourne Stem Cell Centre Goals for web.jpg

Our Goals

 

MSCC is committed to the further development of stem cell based therapies for osteoarthritis.  We have completed recruitment of a world first randomised controlled trial on the use of stem cells in arthritis with results expected to be published in 2018.   MSCC has also partnered with leading medical specialists and has commenced studies in the area of lower back pain. 

Further to the importance of research in appropriate stem cell development, MSCC has partnered with Charles Sturt University in its ongoing research program.